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Autism imposes a major impediment to childhood development and a huge emotional
and financial burden on society. In recent years, there has been rapidly accumulating
genetic evidence that links the eNHE, a subset of Na+/H+ exchangers that localize to
intracellular vesicles, to a variety of neurological conditions including autism, attention
deficit hyperactivity disorder (ADHD), intellectual disability, and epilepsy. By providing
a leak pathway for protons pumped by the V-ATPase, eNHE determine luminal pH
and regulate cation (Na+, K+) content in early and recycling endosomal compartments.
Loss-of-function mutations in eNHE cause hyperacidification of endosomal lumen, as
a result of imbalance in pump and leak pathways. Two isoforms, NHE6 and NHE9
are highly expressed in brain, including hippocampus and cortex. Here, we summarize
evidence for the importance of luminal cation content and pH on processing, delivery
and fate of cargo. Drawing upon insights from model organisms and mammalian cells
we show how eNHE affect surface expression and function of membrane receptors and
neurotransmitter transporters. These studies lead to cellular models of eNHE activity
in pre- and post-synaptic neurons and astrocytes, where they could impact synapse
development and plasticity. The study of eNHE has provided new insight on the
mechanism of autism and other debilitating neurological disorders and opened up new
possibilities for therapeutic intervention.
Keywords: SLC9A9, SLC9A6, sodium proton exchanger, autism, Christianson syndrome, ADHD, endosomes,
trafficking
GENETIC COMPLEXITY OF AUTISM AND
NEURODEVELOPMENTAL DISORDERS
Neurodevelopmental disorders have in common a set of severely
affected behavioral features arising from alterations in early brain
development that result in life-long disabilities affecting not only
the individual but the family and society as a whole (van Loo
and Martens, 2007). A characteristic feature of the etiology of
neurodevelopmental disorders is a complex interplay between
genetics, environment and epigenetic factors. This is exemplified
by autism spectrum disorders (ASD) that encompass a hetero-
geneous collection of neurodevelopmental deficits, with classical
autism manifesting in impaired social behavior, repetitive or
stereotyped interests, and language delays (Kanner, 1943; Howlin
et al., 2000, 2004; Seltzer et al., 2004; Farley et al., 2009). ASD
has emerged as a major public health concern worldwide with an
unmet need for effective and safe interventions, with the most
recent CDC statistics indicating a staggering prevalence of 1 in
68 children (1 in 42 for boys) (Baio, 2014). Individuals with
autism are also at high risk for inattention/hyperactivity disor-
der (14–95%) (Gjevik et al., 2011; Amr et al., 2012; Antshel et al.,
2013), intellectual disability (about 40% cases) and seizures (up
Abbreviations: NHE, sodium proton exchanger; SLC, solute carrier; ASD, autism
spectrum disorders; MRS, magnetic resonance spectroscopy; eNHE, endosomal
sodium hydrogen exchanger; XLID, X-linked intellectual disability; ADHD, atten-
tion deficit hyperactivity disorder.
to 25% cases) (Fombonne, 2003; Canitano, 2007), indicating a
common platform in the genetic architecture of these disorders.
Within the past two decades, evidence has emerged for strong
genetic underpinnings in ASD, estimated at ∼70% in monozy-
gotic twins for classic autism and∼90% for the broad spectrum of
autistic disorders (Folstein and Rosen-Sheidley, 2001; Landrigan,
2010). However, consistent with the diverse spectrum of clini-
cal presentation is a high degree of genetic heterogeneity, which,
together with de novo mutations, has hindered analysis of autism
susceptibility loci (Liu et al., 2008). In fact, no single mutation
accounts for more than ∼1% of non-syndromic cases; rather,
there appears to be a large number of rare variants (Devlin and
Scherer, 2012). Copy number variations and loss of function
mutations that affect only one allele highlight the importance
of gene dosage impacting the affected pathways (Peters et al.,
2013). Although 350–400 genes have been implicated in autism
(Iossifov et al., 2012), few have been supported by functional
studies at a cellular andmolecular level. Future progress in autism
research relies not only on identifying new susceptibility genes
but also on validating the relevance of candidate genes to the
pathogenesis of autism and screening genetic variants for func-
tional changes (Kondapalli et al., 2013). In this review, we will
evaluate the emerging evidence implicating a role for endosomal
Na+/H+ exchangers (eNHE), a subgroup of the NHE superfam-
ily, to autism and other neurological disorders. We briefly review
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relevant studies in model organisms and non-neuronal systems
for much-needed functional insight on potential neurological
roles of eNHE.
Studies on well-defined neurodevelopmental disorders, such
as tuberous sclerosis complex, Fragile X, Timothy, Rett and
Angelman syndromes, which have a high co-occurrence of ASD,
have provided important clues into etiologic mechanisms of
this complex and heterogeneous disorder. One emerging mech-
anism common to ASD is synaptic plasticity (Delorme et al.,
2013) and symptoms of autism emerge in the first few years
of life when experience-based modifications of excitatory and
inhibitory synapses occur. Neuronal activity triggers changes in
transcriptional, translational, signaling and trafficking pathways
to regulate learning, memory and adaptive behavior (Flavell and
Greenberg, 2008). Dysregulation of any of these crucial steps
that control the structure, function and plasticity of the synapse
may contribute to the molecular and cellular basis of ASD.
A fundamental concept of synaptic physiology is the bidirec-
tional flow of information between astrocytes and neurons. In
addition to classic neurotransmitter transmission between pre-
and post-synaptic neurons, the astrocytes process, transfer and
store information to regulate and respond to synaptic transmis-
sion. This three-way communication is described as the tripartite
synapse, a phrase originally coined by Philip G. Hayden (Smith,
1994; Araque et al., 1999). Although not localized at the synap-
tic membrane, eNHE function has been proposed to regulate
vesicular trafficking to affect expression and turnover of criti-
cal components at the synapse. Therefore, we present a cellular
model of eNHE function at each of the three components of
the tripartite synapse, including pre- and post-synaptic neurons,
and astrocytes. The model incorporates observations drawn from
non-neuronal cells and model organisms to propose plausible
mechanisms within the context of known pathways in the etiology
of neurological disorders.
eNHE IN NEURODEVELOPMENTAL DISORDERS
In recent years, numerous independent studies have implicated
NHE6 and NHE9, the two endosomal subtypes (eNHE) of
the Na+/H+ exchanger (NHE) gene superfamily, in multiple
neurodevelopmental and neuropsychiatric disorders, including
autism, severe X-linked intellectual disability (XLID), epilepsy,
addiction and attention deficit hyperactivity disorder (ADHD)
(Table 1). The NHE superfamily of cation/proton antiporters
control pH and ion composition for a wide range of homeostatic
mechanisms in all branches of the tree of life (Brett et al., 2005a).
It is well-known that the transport of ions across membranes is
crucial for regulation of cellular pH, volume, electrical excitabil-
ity and energy provision, and thus indispensable for cell survival
and proliferation (Casey et al., 2010). A slight alteration in the pH
can have profound sequelae: for example, cultured PMC-22 cells
enter cell quiescence with a pHcyt perturbation as little as 0.2 units
(Musgrove et al., 1987). Furthermore, each membrane-bound
organelle must maintain a distinct pH and ionic composition
within its lumen that critically impacts its function (Mellman,
1992; Brett et al., 2006). Endocytosis, like many other dynamic
cellular processes, requires precise tempo-spatial pHlumen regula-
tion critical for proper processing of receptor ligand complexes,
cargo sorting, modulating enzyme activity, membrane protein
and receptor recycling, antigen processing, and as a key check-
point for endosomal sorting machinery and vesicular traffic.
Members of the Na+/H+ exchanger superfamily of membrane
transporters provide the range and flexibility to counter fluc-
tuations in cellular and subcellular environment (Brett et al.,
2005a).
In humans, NHE genes are part of the Solute Carrier 9 (SLC9)
cluster that includes 13 different isoforms organized into distinct
divisions on the basis of phylogenetic relations. However, despite
abundant and wide spread expression in the brain, only a spe-
cific subset of the SLC9 gene family has been linked to autism and
neurodevelopmental disorders. To understand how eNHE may
contribute to these disorders, a brief overview of the evolution-
ary origins and cellular role of NHE isoforms is useful. Readers
are directed to Donowitz et al. (2013) for a more detailed, up to
date review of cation/proton exchangers.
Members of the electroneutral NHE clade (SLC9A) com-
prise 9 isoforms that reside on the plasma membrane (NHE1–5;
SLC9A1–5) or in distinct intracellular compartments (NHE6–
9; SLC9A6–9) including Golgi (NHE8; SLC9A8) and trans-Golgi
network (NHE7; SLC9A7), and in various endosomes (NHE6;
SLC9A6, and NHE9; SLC9A9) (Ohgaki et al., 2011; Donowitz
et al., 2013). Furthermore, the plasma membrane NHE (pNHE)
may be stably resident at the cell membrane (NHE1, 2, and
4) or recycle there and back (NHE3 and 5). Each isoform is
thought to play a distinct cellular role. In general, plasma mem-
brane NHE isoforms regulate cytoplasmic pH whereas the effect
of the intracellular isoforms is primarily on the compartmental
lumen. Plasma membrane NHE function by coupling to the Na+
electrochemical gradient established by the ubiquitous sodium
pump, moving Na+ ions into the cytoplasm in exchange for
removal of H+. Thus, apically localized Na+/H+ exchangers,
like NHE3, are important in sodium reabsorption in the kid-
ney and gut (Donowitz et al., 2013). In contrast, active transport
by endosomal NHE is driven by the H+ gradient generated by
the V-type H+-ATPase, resulting in cation (Na+ or K+) seques-
tration coupled to removal of protons from the compartmental
lumen (Figure 1). Of note, the plasma membrane and endoso-
mal subtypes have different ion selectivity, with the former being
Na+ selective, whereas most intracellular isoforms transport both
K+ and Na+ ions (Ohgaki et al., 2011). In this way, eNHE
activity modulates pH within endosomes and various secretory
organelles, which has been linked to cargo processing, turnover
and trafficking, as described ahead.
FUNCTIONAL INSIGHTS ON eNHE FROM NON-NEURONAL
SYSTEMS
A strong body of literature relating to eNHE activity in non-
neuronal model systems highlights their key role in many funda-
mental cellular functions including endosomal pH regulation and
controlling vesicular traffic. These valuable insights can applied
toward deciphering the role of eNHE in neuronal cells where they
play a role in the etiology of neurological disease. Intracellular
Na+/H+ exchangers have been identified and studied in model
systems ranging from Saccharomyces cerevisiae and other yeasts,
to Arabidopsis and other plants, the nematode Caenorhabditis
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Table 1 | eNHE and neurological disorders.
Mutation
type
Study type Nucleotide change Protein change Phenotype References
SLC9A6
Missense Clinical and mutational analysis c.25G>T (dbSNP:
rs201523857)
p.A9S (1) Angelman-like
syndrome, (2) autism
spectrum disorder
Fichou et al., 2009;
Piton et al., 2011
Droplet-based multiplex PCR
and sequencing
c.563T>C p.L188P XLID Hu et al., 2009
Exome sequencing c.1703G>A p.R568Q (1) XLID, (2)
Schizophrenia
Tarpey et al., 2009(*);
Piton et al., 2011(*);
Santoni et al., 2014(*)
Non-sense Brain MRI, clinical and
mutational analysis
c.916C>T p.Q306X XLID, Christianson type
and retinitis pigmentosa
Mignot et al., 2013
Brain MR spectroscopy, clinical
and mutational analysis
c.1219C>T p.Q407X XLID, Christianson type Schroer et al., 2010
Linkage analysis, DNA
sequencing and biochemical
investigations
c.1498C>T (dbSNP:
rs122461162)
p.R500X (1) XLID, (2)
Angelman-like syndrome
Gilfillan et al., 2008(*);
Tarpey et al., 2009(*);
Schroer et al., 2010
Exome sequencing c.1639G>T p.Glu547X
(truncation of
tail)
XLID Schuurs-Hoeijmakers
et al., 2013
Splicing Brain MRI, Clinical and
mutational analysis
c.680+1G>T XLID, Christianson type Riess et al., 2013(*)
Exome sequencing c.1042-1C>T (dbSNP:
rs149044510)
XLID Piton et al., 2013
Brain MRI, clinical and
mutational analysis
c.526+1G>A XLID, Christianson type Bosemani et al., 2013
Brain MRI, EEG, clinical and
mutational analysis
c.1151-1G>A XLID, Christianson type
and electrical status
epilepticus during
slow-wave sleep (ESES)
Zanni et al., 2014
Small
deletions
Linkage analysis, DNA
sequencing and biochemical
investigations
c.860 865delAAAG TG p.G287 S288del (1) XLID, (2)
Angelman-like syndrome
Gilfillan et al., 2008(*)
Linkage analysis, mutation
screening, electron microscopy
examination, biochemical
investigations
c.1109_1117delGG
AGTACCT
p.W370 T372del XLID, autism spectrum
disorder, tau deposition
and stereotyped,
repetitive hand
movements mimicking
Rett syndrome
Garbern et al., 2010
Clinical, mutational and
biochemical analysis
c.441delG p.S147MfsX9 Angelman-like syndrome Takahashi et al., 2011
Linkage analysis, DNA
sequencing and biochemical
investigations
c.608_609delAT p.H203LfsX60 (1) XLID, (2)
Angelman-like syndrome
Christianson et al., 1999;
Gilfillan et al., 2008(*);
Tarpey et al., 2009(*)
Linkage analysis, DNA
sequencing and biochemical
investigations
c.603+1delGTAA p.V176 R201del XLID Gilfillan et al., 2008(*);
Tarpey et al., 2009(*)
Small
insertions
Brain MRI, Clinical and
mutational analysis
c.1560dupT p.T521YfsX23 XLID, Christianson type Riess et al., 2013(*)
Gross
deletions
Array comparative genomic
hybridization analysis
314 kb involving NHE6
exons 15-16, FHL1,
MAP7D3 and GPR112
genes
XLID, Christianson type Tzschach et al., 2011
Array comparative genomic
hybridization analysis
9 kb partial XLID Whibley et al., 2010
(Continued)
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Table 1 | Continued
Mutation
type
Study type Nucleotide change Protein
change
Phenotype References
Duplications MLPA analysis, fluorescence in
situ hybridization,
X-chromosome-specific aCGH,
breakpoint mapping by
quantitative PCR
2.8Mb involving 24
known genes including
NHE6
Intellectual disability,
short stature,
microcephaly, and
hypopituitarism
Madrigal et al., 2010
Non-coding
SNPs
Clinical and mutational analysis c.1538+8G>A (dbSNP:
rs6654310)
Psychomotor delay and
stereotypes
Fichou et al., 2009
c.1725-4G>A Autism
SLC9A9
Missense Homozygosity mapping and
mutational analysis
c.349C>A (dbSNP:
rs186296463)
P117T Autism with epilepsy Morrow et al., 2008
c.526G>A V176I Autism without epilepsy
c.707T>C (dbSNP:
rs113649536)
L236S Autism without epilepsy
c.1312T>C S438P Autism with epilepsy
c.1486G>A (dbSNP:
rs111291437)
D496N Autism with epilepsy
c.1825C>A Q609K Autism without epilepsy
Candidate gene association
analysis
c.1765A>G (dbSNP:
rs2289491)
I589V Attention deficit
hyperactivity disorder
Brookes et al., 2006
Non-sense Homozygosity mapping and
mutational analysis
c.1267C>T (dbSNP:
rs121912597)
R423X Autism with epilepsy Morrow et al., 2008
Splicing Homozygosity mapping and
mutational analysis
c.1524+3A>G Autism without epilepsy Morrow et al., 2008
Deletions SNP arrays and mutational
analysis
12 kb partial Autism spectrum
disorder
Ben-David et al.,
2011
Homozygosity mapping and
mutational analysis
Non-coding 5′ NHE9 and
entire DIA1 gene
Autism Morrow et al., 2008
Complex
rearrange-
ments
Biochemical investigations,
association and linkage studies
Inv (3)(p14:q21) Attention deficit
hyperactivity disorder
de Silva et al., 2003
Non-coding
SNPs
Candidate gene association
analysis
Multiple SNPs Attention deficit
hyperactivity disorder
Brookes et al., 2006
GWAS Multiple SNPs Attention deficit
hyperactivity disorder
Lasky-Su et al., 2008
Family based GWAS dbSNP: rs9810857 Attention deficit
hyperactivity disorder
Mick et al., 2010
GWAS, clinical and MRI analysis c.534-13829C>T (dbSNP:
rs9828519)
Multiple sclerosis,
non-response to
interferon-ß
Esposito et al., 2013
Network based GWAS c.1604+13022A>G
(dbSNP: rs6775025)
SNP with lowest p-value
for smoking initiation
Vink et al., 2009
c.378+8918C>G
(dbSNP: rs4839669)
SNP with lowest p-value
for current smoking
ADHD clinical assessment
tools, genotyping
c.*444C>A (dbSNP:
rs1046706)
ADHD-related deficits on
impulsiveness and
hyperactivity
Markunas et al., 2010
c.649+6371C>T (dbSNP:
rs2360867)
ADHD-related deficits on
commission errors
Survey of studies implicating eNHE in a range of neurological disorders.
Abbreviations: del, deletion; fs, frame-shift; Inv, inversion; SNP, single nucleotide polymorphism; dbSNP, NCBI SNP database entry; XLID, X-linked intellectual
disability; X, termination; (*) Mutations are referred to in relation to longer NHE6.1 isoform (NP_001036002.1).
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FIGURE 1 | The Pump-Leak hypothesis of endosomal pH regulation.
Endosomal pH is precisely tuned by a combination of proton pumping or
acidification through the V-ATPase and proton leaking or alkalization via
endosomal Na+(K+)/H+ exchangers (eNHE), both evolutionarily conserved
from yeast to plants and mammals. In mammalian cells, under physiological
conditions, the endosomal pH is acidic (≈5.7) relative to the cytoplasmic pH
(≈7.2). As per the pump-leak hypothesis, the H+ gradient generated by the
V-ATPase (V-type H+-ATPase) drives secondary active transport by eNHE,
resulting in cation (Na+ or K+) sequestration coupled to removal of protons
from the compartmental lumen. From this model it is intuitive that eNHE
activity would provide the range and flexibility to counter fluctuations in
subcellular environment. Also, loss-of-function mutations in eNHE would
cause hyperacidification of endosomal lumen, as a result of imbalance in
pump and leak pathways, impacting cargo processing, turnover, and
trafficking. In addition to the intricate balance between proton pump and leak
pathways, counter-ion (anion and cation) conductances (not shown) also
contribute to pH homeostasis. The pH values indicated in the figure were
collected from published literature (Casey et al., 2010; Kondapalli et al., 2013).
elegans and flies, including Drosophila and mosquito, and more
recently using knockout models in mouse. Each of these systems
has provided unique insight that may be extrapolated to human
counterparts. From yeast, it is apparent that endosomal NHE
largely impacts intracellular trafficking pathways by modulating
luminal pH (Brett et al., 2005b). In plants, vacuolar NHE mod-
ulate flower color by altering luminal pH (Fukada-Tanaka et al.,
2000), confer salt tolerance and resistance to osmotic stress, regu-
late stomatal movements, and affect leaf development (Apse et al.,
1999; Andres et al., 2014), while eNHE orthologs that localize to
endosomal compartments in the plant cell have been postulated
to play a role in trafficking and regulation of vesicular function
(Pardo et al., 2006).
A useful strategy to obtain preliminary information on ion
selectivity and pH dependence of mammalian NHE is by comple-
menting knockout phenotypes of the orthologous gene (NHX1)
in yeast. We found that NHE6 and NHE9 both conferred salt
tolerant growth in medium adjusted to pH 7–7.5, but not at
acidic pH (Hill et al., 2006). Yeast NHX1, however, was able
to confer salt tolerance over a wide range of pH. Since alkaline
medium was found to elevate vacuolar pH but not cytoplasmic
pH (Brett et al., 2011), these observations hint at a potential role
of luminal pH in regulating mammalian endosomal NHE activ-
ity. The ion-selectivity of NHE6 and NHE9 was evaluated using
this heterologous system. Both genes complemented host sensi-
tivity to Na+ and K+, but not to Li+ or Rb+. Yeast NHX1 differs
in the ability to also transport Rb+, as shown by relative tolerance
to RbCl toxicity and 86Rb transport (Brett et al., 2005b).
Relative to work done on the plasma membrane isoforms,
functional characterization of mammalian endosomal NHE has
been conspicuously slow. This is in part due to the method-
ological limitations. Standard assays of plasma membrane-NHE
activity which follow pH-dependent recovery of BCECF fluores-
cence after acidification of cytosol, consistently failed to detect
endosomal-NHE function, whereas measurement of luminal pH
using compartment specific pH-sensitive GFP constructs often
show modest changes, possibly in part due to the buffering role
of GFP itself inside small vesicles. In COS7 cells, Nakamura
et al. observed an elevation of 0.4 pH units in recycling endo-
somes upon overexpression of NHE9 (Nakamura et al., 2005).
In the latter study, no effect of NHE6 overexpression was
observed possibly due to non-overlapping distribution with the
pH probes. Depending on cell type, there is a partial overlap
in the distribution of NHE6 and 9 in endosomes, such that
luminal acidification has been observed upon NHE6 knockdown
either singly (HepG2 cells and HeLa cells) (Ohgaki et al., 2010;
Xinhan et al., 2011) or in combination with NHE9 knockdown
(HeLa cells) (Roxrud et al., 2009). In an elegant study of audi-
tory hair cells, Hill et al. (2006) demonstrated a role for NHE9
in pH homeostasis in the stereocilia. They showed that Ca2+/H+
exchange by plasma membrane Ca2+-ATPase resulted in rapid
acidification of the hair bundles and that electroneutral K+/H+
activity by NHE9 exploited the K+ rich endolymph surround-
ing hair bundles to prevent overacidification. In these specialized
cells, NHE9 was localized to the plasma membrane of stereocilia,
in addition to vesicles in the cell body and contributed to pH
homeostasis of the hair bundles, independently of the cell body
(Hill et al., 2006).
The yeast model has taught us that effects of NHX1 on
trafficking are robust and easy to monitor. Indeed, this has been
borne out by more recent and insightful studies investigating
the role of mammalian eNHE in trafficking: Muro et al. showed
that in endothelial cells cargo becomes associated with NHE6-
positive compartments 3 h following endocytosis. Furthermore,
they showed that monensin, an ionophore known to abolish
Na+/H+ gradients, blocks lysosomal delivery and reroutes traffic
to the surface (Muro et al., 2008). Using transferrin uptake
assays, NHE6 activity was implicated in clathrin-mediated
endocytosis (Xinhan et al., 2011). In the polar hepatocyte cell
model, HepG2, Ohgaki et al. showed colocalization of NHE6
to recycling endosomes (both sorting endosomes and the
subapical compartment) where it was required for retention of
apical membrane components and maintenance of cell polarity.
Following isoform-specific knockdown and overexpression of
NHE6, they observed a decrease and increase of endosomal pH,
respectively, that ultimately affected the polarized distribution of
membrane lipids at the apical surface. In addition, they clarified
that maintenance, but not biogenesis, of the apical membranes is
regulated by NHE6 (Ohgaki et al., 2010).
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INSIGHTS FROM INTERACTING PARTNERS
The presence of several human disease mutations in the
C-terminal tail of eNHE point to an important functional role
of this domain (Figure 2; Table 1). For instance, Arg568Gln in
the C-terminus of NHE6.1 isoform (Arg536Gln in the shorter
NHE6.0 isoform) was identified in three independent reports:
two in males with intellectual disability (hemizygous) and one
in a female with schizophrenia (heterozygous) (Tarpey et al.,
2009; Piton et al., 2011; Santoni et al., 2014). The cytoplasmic C-
terminal tail of the NHE lies outside the membrane-embedded
transport domain and is not considered essential for ion trans-
port. However, the C-terminal domain may act as a scaffold for
binding of multiple proteins that regulate transport kinetics and
trafficking. Therefore, the role of interacting proteins at the C-
terminus of eNHE is of special interest to understanding the
molecular and cellular basis of autism and related neurological
disorders.
Hydropathy analysis of the Na+/H+ exchangers predicts a
common membrane topology shared by all isoforms (NHE1–
9): an N-terminal hydrophobic membrane-embedded domain
consisting of 12 transmembrane segments and a hydrophilic
C-terminal domain, facing the cytoplasm. Much of the con-
servation between NHE isoforms (up to 70% in amino acid
similarity) is restricted to the N-terminal transporter domain,
with the C-terminus being more divergent. For example, in
the C-terminus, the amino acid identity between NHE1 (res-
ident, plasma membrane isoform) and the eNHE is ∼8–10%
and sequence similarity is ∼37–41%, whereas within the two
endosomal isoforms the identity and similarity are ∼42 and
87%, respectively. This suggests that distinct interactions at the
C-terminus probably have an effect on the localization and regu-
lation of the eNHE. There are many published studies on the role
of interacting partners of plasma membrane NHE, particularly
NHE1 and NHE3, linking transporter function to cytoskeleton
and signal transduction (Donowitz et al., 2013). In principle,
some of the known interacting partners of well-studied pNHE,
for instance an autism-associated scaffolding protein Shank2
shown to interact and regulate NHE3 activity (Han et al., 2006),
might be useful candidates in the search for binding partners
of eNHE.
Specific interacting partners of the eNHE have been reported.
RACK1 (Receptor for Activated C-Kinase 1), previously shown
to be an adaptor and a scaffold protein, interacts with NHE 6,
7, and 9 in vitro and was shown regulate the cellular localiza-
tion of NHE6 (Ohgaki et al., 2008). While the bulk of NHE6
is localized in early/recycling endosomes, it appears transiently
on the plasma membrane (Brett et al., 2002). Surface biotinyla-
tion studies showed that knockdown of RACK1 decreased surface
expression of NHE6 without changing total protein levels. This
decrease on the surface was accompanied by elevation of endoso-
mal luminal pH and decreased uptake of transferrin, a marker
for the recycling pathway. The only other published interac-
tion of NHE6 is with Angiotensin II receptor subtype 2 (AT2).
Angiotensin II (Ang II) has been shown to regulate sodium home-
ostasis by binding to its receptors AT1 and AT2, which mediate
opposing signaling mechanisms. Using AT2 as bait in a yeast
two-hybrid approach, Pulakat and coworkers identified a pep-
tide of NHE6. They showed that AT2 co-immunoprecipitated
with hemagglutinin tagged-NHE6 when expressed in a human
breast cancer cell line, MCF-7, but only under conditions where
the cells were treated with Ang II, suggesting that the interaction
is ligand mediated (Pulakat et al., 2005). A number of human
mutations have been reported in the AT2 including some involv-
ing NHE6 binding region of AT2. Intriguingly, human mutations
FIGURE 2 | Gene Distribution of patient mutations in NHE6 and NHE9.
(A,B) The distribution of NHE6 (A) and NHE9 (B) mutations (missense,
non-sense, and in-frame deletions) in N-terminal transmembrane domain
and the C-terminal regulatory cytoplasmic domain, listed in Table 1, are
displayed. The x-axis indicates amino acid locations of NHE6 and NHE9
proteins, while the y-axis displays the number of published literature
reports. All mutations in NHE6 are referred to in relation to longer NHE6.1
isoform (NP_001036002.1).
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in AT2 are also reported to result in XLID and epilepsy and
might have overlapping clinical features with NHE6 mutations
(Vervoort et al., 2002; Takeshita et al., 2012). In the case of
NHE9, co-immunoprecipitation of tagged constructs expressed
in HEK293 cells revealed an interaction with the calcineurin
homologous protein CHP, previously shown to bind to the C-
tail of pNHE isoforms (Lin and Barber, 1996; Zhang-James et al.,
2012). Interestingly, a C-terminal NHE9 variant V512G/K534R
found in a rat model of inattentive behavior showed a 2-fold
increase in binding CHP, although the functional implication of
this remains to be determined (Zhang-James et al., 2012).
PATIENT MUTATIONS IN eNHE: GENE DISTRIBUTIONS AND
STRUCTURAL INSIGHTS
A plethora of genetic studies has uncovered numerous clini-
cally relevant patient mutations in SLC9A6 and SLC9A9 genes,
encoding NHE6 and NHE9 respectively. These span the gamut
of missense and non-sense mutations, both large and small dele-
tions and insertions, splice site mutations, microduplications and
non-coding single nucleotide polymorphisms, and are listed in
Table 1. Gene alterations are distributed throughout the open
reading frame, localizing within the N-terminal membrane span-
ning transporter domain, and the cytoplasmic C-terminal tail
(Figure 2). Although invaluable in training a spotlight on the
eNHE, genetic analyses and gene sequencing approaches alone
do not provide definitive functional insight in the absence of
structure-function information. Functional evaluation of disease-
associated eNHE variants will be essential to predict clinical
outcome, as a prerequisite to personalized therapy in patients
with autism and other neurological diseases. Thus, a given alter-
ation may be a harmless polymorphism or causal to the disease.
Mutations may exert their effect through loss or a gain of func-
tion and in the case of single allele alterations these may exert
their impact through haploinsufficiency or a dominant effect.
Therefore, it is imperative to validate patient mutations using a
combination of structure-based and functional tools. In the next
section we will briefly discuss model-structures of eNHE that
could be used as a template for structure-driven assessment to
predict functionally significant gene variants.
Three dimensional protein structures are a requisite first
step toward interpreting functional effects of gene variants in
eNHE. Although atomic-level structures of mammalian Na+/H+
exchangers have not been experimentally derived, crystal struc-
tures of bacterial CPA orthologs serve as templates for predictive
model-structures based on a common protein fold, supported
by evolutionary conservation analysis and empirical data. The
low sequence identity (∼15%) across large evolutionary distances
separating bacterial and mammalian orthologs makes the model-
ing challenging, requiring state of the art approaches to construct
sequence alignments, which are then used to build three dimen-
sional homology models of NHE isoforms based on the template
structure of E. coli NhaA (Figures 3A,B) (Hunte et al., 2005;
Kondapalli et al., 2013). More recently, the crystal structure of
the T. thermophiles NapA antiporter was obtained in a distinct
outward-facing conformation (Lee et al., 2013), providing fur-
ther evidence for the broadly accepted alternating access model
of antiport. Together, the structures reveal a unique two-domain
rocking bundle of twelve transmembrane helices with a dimeriza-
tion domain showing extensive helix contacts between adjacent
monomers. The translocation domain contains a pair of distinc-
tive crossing helices that are partially unwound in the middle of
the bilayer, the TM4–TM11 assembly (Figures 3A,B) proposed
to provide a delicate electrostatic balance for nearby charged
residue(s) that form the putative cation binding site. Importantly,
the most highly conserved residues in the model-structures local-
ize to helix interfaces within the transmembrane core, whereas the
more variable residues lie in loops or face the lipid bilayer (Landau
et al., 2007). Substitutions of highly conserved residues, particu-
larly within structures important for transport function, are likely
to disrupt transport function.
Missense mutations and in-frame deletions in SLC9A6 and
SLC9A9 from the studies listed in Table 1 have been mapped
onto the model-structures (Figures 3A,B). In the absence of an
equivalent domain, the C-terminal tails of mammalian NHE
could not be modeled, and are represented in Figure 3C. Other
variants that introduce non-sense (stop) codons within the mem-
brane embedded transporter domain are not indicated, and are
expected to result in clearance of truncated polypeptides or
in non-sense-mediated transcript decay. While some patient-
associated variants introduce non-conservative substitutions
within highly conserved domains, others lie in more variable
regions of the transporter.
With the advent of personal genomics on the horizon, and
the prevalence of many rare variants in individual genotypes,
it will be important to have in place defined strategies to eval-
uate functional consequences of amino acid changes in eNHE
that may be linked to neurodevelopmental disorders. One such
strategy involves phenotype complementation in a yeast expres-
sion system, using the yeast ortholog as a surrogate in an initial
screen for function. Functional evaluation of a subset of mis-
sense mutations reported for NHE9 revealed that changes in
conserved residues could readily be modeled in yeast and gave
consistent loss-of-function effects in both yeast andmurine astro-
cyte models (Kondapalli et al., 2013). However, a substitution in
a more variable region that resulted in functional deficiency in
the astrocyte cell model, failed to show difference from wild type
protein in yeast. Although more extensive testing of patient vari-
ants is warranted, this limited study suggested that residues with
an evolutionary score of 5 or better (on a scale of 1–8, with 8
being most conserved; Kondapalli et al., 2013) could be readily
amenable to rapid and inexpensive functional evaluation using
phenotype screening in yeast. Less conserved substitutions may
have to be evaluated in a neurobiological model. Thus, structure-
driven assessment of gene variants in a simple yeast model
complemented with neuronal/astrocytic models would provide
a rapid, inexpensive and accurate functional screen for eNHE
gene variants to distinguish between harmless polymorphisms
and disease-associated mutations.
PATIENT MUTATIONS IN eNHE: CLINICAL FEATURES
Patient mutations in eNHE present an unexpectedly large range
of neurodevelopmental disorders, with distinct but overlap-
ping phenotypes. The complexity of clinical presentation has
remained largely unexplained at a functional level, particularly
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FIGURE 3 | Model-Structures of NHE6 and NHE9 with patient mutations.
(A,B)Model of NHE6 (A) and NHE9 (B) are based on methods described in
detail elsewhere (Landau et al., 2007; Kondapalli et al., 2013). Side views of the
membrane embedded N-terminal transporter domains are shown, with the
cytoplasm below. The TM4–TM11 assembly (colored yellow and green,
respectively) is key to the antiport mechanism, and consists of extended
segments of the two helices, crossing each other in the middle of the
membrane. For clarity, TM3 backbone is shown in stick configuration and a part
of the TM1–2 loop of NHE9 was omitted. Positions in which clinical mutations
were detected aremarked, shown as all-atom spheres and colored according to
their ConSurf evolutionary conservation scores (Ashkenazy et al., 2010,
http://consurf.tau.ac.il/) as follows: strongly conserved residues (magenta),
weakly conserved (white), non-conserved (blue). Many of the conserved sites
that show substitutions are situated in highly packed regions, including the
vicinity of the TM4–TM11 assembly region. P117 of NHE9, on the other hand, is
located in the very long and variable loop connecting TM1 and TM2. A minor
substitution to Ile was found in V176 of NHE9, a moderately-conserved
hydrophobic residue that is oriented toward the lipid bilayer. Three
autism-associated variants in NHE9 (L236S, S438P, V176I; Table 1) have been
experimentally determined to be loss of function mutations (Kondapalli et al.,
2013), the remainder remain to be screened for changes in function. (C)
Sequence alignment of C-terminal tail extensions of human NHE6, human
NHE9, and rat NHE9. The positions of human NHE6 and NHE9 disease variants
in the C-terminal tail are boxed (Table 1). Missense variants reported in rat
models of attention deficit/hyperactivity disorder are also indicated
(Zhang-James et al., 2011). Highly conserved RACK1 binding region in the
C-terminus of NHE6 and NHE9 and the Angiotensin II receptor (AT2) interacting
region in the juxtamembrane portion of the NHE6 C-terminus are displayed.
in the context of neurobiology and function of the synapse.
Herein, we seek to consolidate all relevant clinical data on eNHE
that span a range of patient symptoms as a starting point for
genotype-phenotype correlations and to aid clinical decision
making.
NHE6 (SLC9A6)
SLC9A6, the gene encoding NHE6, is one of six most recur-
rently mutated loci in patients with XLID and has been linked
to autism comorbid with seizures (Tarpey et al., 2009). Mutations
in the NHE6 gene commonly present with prominent neurolog-
ical phenotypes associated with syndromic autism that can be
broadly characterized into four overlapping clinical categories,
summarized in Table 1 and described below.
(i) Christianson syndrome: Christianson et al. first described
a XLID syndrome localized to Xq24-q27 in a South African
family presenting with autistic features and cerebellar atro-
phy (OMIM 300243)1 (Christianson et al., 1999). A follow-
up study on this family located the causative NHE6mutation
and reported three additional families with the disorder
(Gilfillan et al., 2008). Christianson syndrome is charac-
terized by severe developmental delay, early onset seizures,
ataxia, hypotonia, and microcephaly in males. At least fif-
teen unique mutations in SLC9A6 have been reported thus
far (Schroer et al., 2010; Stromme et al., 2011; Tzschach et al.,
1OMIM 300243. Online Mendelian Inheritance in Man, OMIM®. Available
online at: http://www.omim.org/entry/300243
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2011; Mignot et al., 2013; Riess et al., 2013) (Table 1). A
314 kb deletion in the Xq26.3 region affecting NHE6 and
FHL1 genes in a 2-year-old boy was associated with symp-
toms of severe intellectual disability, absent speech, ataxia,
and epilepsy likely from functional deficits in NHE6, whereas
FHL1 gene disruption was associated with later onset of
muscular dystrophy (Tzschach et al., 2011). A mutation in
SLC9A6 in a 22-year-old male introduced a stop codon at
amino acid residue Gln306 (Mignot et al., 2013). Pervasive
developmental disorder 2 followed by profound intellectual
disability was observed in this patient, as well as retinitis
pigmentosum, previously unreported in Christianson syn-
drome. A study showing novel SLC9A6 gene mutations in
Christianson syndrome males noted signs of Parkinsonism
in obligate carrier females from the same families, suggesting
a predisposition to late-onset neurodegenerative disorders
(Riess et al., 2013).
(ii) Angelman-like syndrome: Several clinical syndromes
share overlapping clinical and behavioral phenotypes
with Angelman Syndrome (AS), and thus are sometimes
misdiagnosed (see Seltzer and Paciorkowski, 2014; Tan
et al., 2014 for detailed review). Recognition of the overlap
in the clinical spectra of Angelman-like syndromes is
important for differential diagnosis and clinical decision
making. Patients with NHE6 mutations share several clinical
features with Angelman syndrome including developmental
delay, postnatal microcephaly, language impairment, happy
demeanor, frequent laughter, drooling, ataxia, seizures,
and stereotypic behaviors (Fichou et al., 2009; Schroer
et al., 2010). Reports in literature have described mutations
in NHE6 in patients clinically diagnosed with AS. While
most cases of AS are linked to the 15q11-q13 region of
the chromosome associated with disruption of UBE3A
gene expression, 10–15% of the cases are due to alternative
genetic mechanisms (Williams et al., 2001). Patients with
AS share phenotypes with Rett syndrome, characterized
by mutations in MECP2 gene. Gilfillan et al. investigated
candidate genes in patients with phenotypes that resembled
Angelman syndrome but did not have mutations in the
UBE3A or MECP2 genes (Gilfillan et al., 2008). Linkage
analysis and DNA sequencing studies identified mutations
disrupting SLC9A6 in patients from multiple families
(Table 1). These patients exhibit a slow progression of
symptoms, with resemblance to Angelman syndrome being
more striking at a younger age. Proton magnetic resonance
spectroscopy data from an effected patient showed elevated
levels of glutamate-glutamine complex in the basal ganglia
which could be associated with a variety of the clinical
neurological abnormalities, including epilepsy and cere-
bellar degeneration (Gilfillan et al., 2008). Unlike classic
Angelman, which is characterized by obesity, patients with
mutations in SLC9A6 are lean. They also show a distinct
2National Institute of Mental Health. Autism Spectrum Disorders
(Pervasive Developmental Disorders). Available online at:
http://www.nimh.nih.gov/health/publications/autism/index.shtml [Accessed
03/07/2014].
EEG pattern (rapid background frequency of 10–14Hz
vs. slow frequency of 1.5–3Hz) (Gilfillan et al., 2008). It
has recently been proposed that cerebellar atrophy and/or
hyperintensity of cerebellar cortex could serve as specific
neuroimaging hallmarks of NHE6 mutations, distinct
from AS patients (Bosemani et al., 2013). The genetic and
molecular basis of the overlap in phenotypes between NHE6
mutations and AS remains largely unknown. Intriguingly,
in NHE6 knockout mice, there is extensive degeneration
in the hippocampal neurons and in cerebellar Purkinje
cells, sites of expression of the maternal allele of UBE3A
(Albrecht et al., 1997; Stromme et al., 2011). It is worth
noting that both NHE6 and UBE3A are activity-regulated
MEF2 target genes that may regulate activity-dependent
synaptic plasticity during neural network development
(Flavell et al., 2008).
(iii) Corticobasal degeneration with tau deposition: Garbern
et al. described a family with intellectual disability accompa-
nied by virtual absence of speech, autism spectrum disorder,
epilepsy, late-onset ataxia, weakness, and dystonia (Garbern
et al., 2010). Intriguingly, affected males in the family did
not show Angelman-like phenotype. Instead, several of the
affected males had stereotyped, repetitive hand movements,
a phenotype mimicking Rett syndrome (Chahrour et al.,
2008). The disorder mapped to an in-frame 9 base pair
deletion in SLC9A6. Histopathological examination of post-
mortem brain tissue from these patients showed wide spread
neuronal loss, gliosis and deposits of the hyperphosphory-
lated microtubule binding protein tau (predominantly 4R
type) in tangles and inclusions in neurons and glia. Loss of
NHE6 function is the likely molecular mechanism for the
cellular dysfunction associated with this mutant (Ilie et al.,
2013).
(iv) Epilepsy: Epilepsy is a common comorbidity seen in autism
and intellectual disability (Canitano, 2007). Grand mal
epilepsy has been reported in 87.5% of patients from a
family with NHE6 mutation (Christianson et al., 1999).
Independent observations of increased levels of glutamate-
glutamine complex in the basal ganglia in the basal ganglia in
MR spectroscopy analysis of patients with NHE6 mutations
suggest that increased glutamate concentration in the brain
might induce seizures (Gilfillan et al., 2008; Schroer et al.,
2010). NHE6 mutations are associated with electrical status
epilepticus during slow-wave sleep (ESES), a form of severe
epileptic disorder (Zanni et al., 2014). Controlling seizures in
patients with intellectual disability is known to improve clin-
ical outcomes and quality of life (Jozwiak et al., 2011). Given
that neuronal pH dysregulation has been linked to origin and
progression of seizure activity (Somjen, 1984), correction of
endosomal pH with drugs that alkalinize endosomal com-
partments might be a useful therapeutic strategy to limit the
progression of the disease.
In addition, to gene deletions and mutations, microduplica-
tions in Xq26.2-q26.3 involving NHE6 have been reported
in patients with intellectual disability, short stature, micro-
cephaly, and hypopituitarism (Madrigal et al., 2010). Similar
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clinical presentations have been described with MECP2 muta-
tions, wherein both loss of function mutations and increased
gene dosage resulting from gene duplications are associated with
prominent neurological phenotypes including intellectual dis-
ability (Chahrour et al., 2008; Peters et al., 2013).
NHE9 (SLC9A9)
A range of clinical presentations have been linked to mutations in
the SLC9A9 gene expressing NHE9 (Table 1; Figure 2). Mutations
in NHE9 present with distinct albeit overlapping phenotypes to
those of NHE6, suggesting unique, non-compensating functions
of the two isoforms.
(i) Autism: The susceptibility to autism-16 (AUTS16) locus on
chromosome 3q is associated with mutations in the NHE9
gene, SLC9A9 (OMIM: 613410)3 . Homozygosity mapping,
microarray, and sequencing data from families of autism
patients with shared ancestry showed a chromosomal dele-
tion in a potentially regulatory non-coding region upstream
of SLC9A9 (Morrow et al., 2008). Other autism associated
deletion mutations involving NHE9 have been also reported
in the literature (Ben-David et al., 2011; Wagle and Holder,
2014). Furthermore, in non-consanguineous autistic pedi-
grees several rare coding variants and a non-sense mutation
truncating the last predicted extracellular loop of the 10–12
membrane-spanning NHE9 protein were identified in patients
with autism and epilepsy (Morrow et al., 2008). We evalu-
ated three representative autism-associated variants for NHE9
function using model structure-based evolutionary conserva-
tion analysis, phenotype screening in yeast and pH-dependent
analysis of trafficking in primarymouse astrocytes (Kondapalli
et al., 2013). The study revealed that patient mutations could
cause loss of ion transport function in NHE9, resulting in
altered endosomal trafficking and cell surface expression of
receptors and neurotransmitter transporters. Contrasting with
loss of function effects, a statistical analysis by Schwede et al.
found upregulation of SLC9A9, along with downregulation
of SLC9A6 in autistic brains relative to non-autistic controls,
emphasizing the importance of gene dosage in the autism phe-
notype (Schwede et al., 2014). SLC9A9 was also one of the
differentially expressed genes across multiple expression data
sets that were within 10 cM of an autism-implicated locus.
Genomic information for this study was collected fromAutism
Genetic Resource Exchange (AGRE) families (Vardarajan et al.,
2013).
(ii) Attention deficit hyperactivity disorder (ADHD): SLC9A9
has been associated with ADHD, a heritable neuropsy-
chiatric disorder. A genome wide scan of 126 affected
sibling pairs identified a Quantitative Trait Locus (QTL)
peak occurring at marker D3S1569, located in intron 5
of SLC9A9 (Fisher et al., 2002). A year later, de Silva
et al. published a clinical report showing ADHD and intel-
lectual disability co-segregating with a pericentric inver-
sion of chromosome 3 that disrupted SLC9A9 along with
3OMIM 613410. Online Mendelian Inheritance in Man, OMIM®. Available
online at: http://www.omim.org/entry/613410
DOCK3 (de Silva et al., 2003). Genome wide association stud-
ies (GWAS) provide an opportunity to identify even non-
classic disease risk genes that have a relatively milder effect in
heterogenetic disorders. In a sample set of 958 parent-child
trios, SLC9A9 had the strongest overall association among
the candidate genes they studied (Lasky-Su et al., 2008).
Multiple association studies identified SNPs in SLC9A9 to be
significantly associated with ADHD and one study identified
SNPs in six distinct regions of the gene. More recently, in
a rat model of inattentive ADHD, age dependent abnormal
expression of NHE9 and mutations that altered interaction
with calcineurin homologous protein (CHP) were reported
(Zhang-James et al., 2011).
(iii) Addiction: Smoking initiation and current smoking are habits
that have a genetic susceptibility component. In a network
based GWAS study, SLC9A9 stood out in a functional group
with glutamate signaling, including the glutamate receptor
and transporter (Vink et al., 2009). Furthermore, a family-
based GWAS study identified significant associations between
SLC9A9 variants and alcohol-dependence phenotypes (Wang
et al., 2013). The association of SLC9A9 with inattention,
smoking initiation, and alcohol dependence suggests a genetic
connection between attention-deficit hyperactivity disorder
and addictive behavior.
(iv) Alzheimer’s Disease and Multiple Sclerosis: eNHE may be
potential risk factors common to both neurodevelopmen-
tal and neurodegenerative diseases. NHE6 has been impli-
cated in Parkinsonism and deposition of tau neurofibrillary
tangles (Garbern et al., 2010; Riess et al., 2013); similarly,
emerging evidence links NHE9 with chronic neurodegener-
ative conditions, including Alzheimer’s disease and multiple
sclerosis. Significant association between NHE9 variants and
Alzheimer’s disease were identified in recent GWAS studies
(Martinelli-Boneschi et al., 2013; Perez-Palma et al., 2014).
Multiple sclerosis (MS) is an inflammatory demyelinating
condition of the brain. A GWAS performed to compare
responders vs. non-responders to interferon beta (IFNβ) treat-
ment found significant association of an intronic NHE9 vari-
ant (rs9828519) with non-response to IFNβ therapy in MS
patients (Esposito et al., 2013). In addition, polymorphisms
within NHE9 have been reported in association with N-
glycosylation variations, a common molecular mechanism in
MS (Huffman et al., 2011; Mkhikian et al., 2011). Further
studies are awaited to understand the link between NHE9 and
multiple sclerosis. One possibility, based upon findings from
model organisms and cultured cells, is that dysregulation of
endosomal recycling of the IFN receptor could link NHE9
activity and response to IFNβ therapy.
In summary, clinical phenotypes resulting from genetic aber-
rations in SLC9A6 and SLC9A9 are distinct and diverse,
despite overlapping endosomal cellular distributions of the
two NHE isoforms. This indicates that NHE6 and NHE9
are non-redundant, and likely to differ in one or more of
the following, including (i) brain expression patterns, (ii)
precise subcellular distribution, (iii) transport function and
regulation.
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DISTRIBUTION OF eNHE IN THE BRAIN
The spatial and temporal regulation of eNHE expression in the
brain may hold clues to their distinct and diverse phenotypes,
including autism and neurological disorders. Indeed, NHE6 and
NHE9 show distinct spatial (Figure 4) and temporal patterns
of expression (Figure 5B). NHE6 is widely expressed in human
brain and shows highest expression prenatally, decreases post-
natally and again peaks during adulthood. On the other hand,
NHE9 expression is far lower embryonically, increases postna-
tally to peak in adulthood (Figure 5B) (Sunkin et al., 2013).
In-situ hybridization studies on the mouse brain indicate that
the expression levels of NHE6 and NHE9 are high in the cor-
tex relative to the other regions of the brain (Lein et al., 2007;
Kondapalli et al., 2013), consistent with impairments in commu-
nication, social deficits, and cognitive function (Kanner, 1943;
Howlin et al., 2000, 2004; Seltzer et al., 2004; Farley et al., 2009).
Highest expression for NHE6 is observed in the hippocampus,
which plays an important role in long-termmemory (Figure 5A).
The expression level of NHE9 in this region is next only to the
olfactory lobe and cortex (Figure 5A). Although the significance
of these expression patterns remains to be determined they are
consistent with distinct and non-overlapping roles for the two
eNHE isoforms. The robust expression levels of eNHE in areas
potentially associated with ASD (Santangelo and Tsatsanis, 2005;
Mitchell et al., 2009) may reflect the importance of ion and pH
homeostasis on the normal functions of the cells in these regions
of the brain.
Genetic architecture and co-expression networks may be
important in understanding autism pathogenesis. To gather
functional insights into the inherent patterns of co-expression
between eNHE and other known ASD genes, we compared
expression of eNHE with a “benchmark” gene set, consist-
ing of 21 genes with strong evidence for ASD association,
described previously (Xu et al., 2012). eNHE clusters with many
synapse associated ASD genes during normal brain develop-
ment (Figure 5C). Notably, a strong correlation was observed
for NHE6 with NRXN1 a well-known autism candidate gene
(Sudhof, 2008). Similar studies on postmortem autism brains
also revealed altered eNHE expression and strong correlation
with other synapse genes (Schwede et al., 2014). Furthermore, a
strong induction of eNHE gene expression was observed during
neuronal differentiation (Konopka et al., 2012). These obser-
vations strengthen the hypothesis that mechanisms regulating
endosomal pH and eNHE activity may play an important role
in brain development, neuronal differentiation, and synaptic
function.
FIGURE 4 | Expression of eNHE in the hippocampus, cerebral cortex,
and cerebellum. (A,B) Brain morphology depicted using cartoon atlas
and Nissl staining indicating coronal (A) and sagittal (B) planes of
hippocampal formation (HPF), with the functionally distinct CA1, CA2,
CA3, and dentate gyrus (DG) subfields. In Situ Hybridization (ISH)
images of NHE6 and NHE9 expression in coronal (A) plane and sagittal
(B) planes of hippocampus accompanied by false-color heat map
adjacent to it, showing enriched eNHE expression in DG and CA1–CA3
(NHE6) and DG and CA1 (NHE9) (A,B, ISH and heat-map). NHE9
expression is also seen in the wall of lateral ventricle (VL) (A, ISH and
white arrow in the heat-map). (C) Cartoon atlas and Nissl staining
depicting cerebral cortex (CTX) in sagittal plane with labeled cortical
layer boundaries. NHE9 is expressed in a gradient in the cortical layer
subfield, in contrast to an NHE6 that is strongly expressed throughout
the cortex (C, ISH and heat-map). (D) Cartoon atlas and Nissl staining
showing cerebellar cortex (CBX) in sagittal plane. Prominent NHE6
expression is seen in the Purkinje cells arranged in a single layer
between the molecular (mo) and granular (gr) layers. In contrast, NHE9
shows weak expression in the cerebellum (D, ISH and heat-map).
False-color reference heat map (expression mask) scale indicating those
cells that have the highest probability of gene expression (from
low/blue to high/red). ISH expression data are from Allen Brain Atlas
obtained from 56 day (8 weeks) old adult male C57BL/6J mice
(available from: http://mouse.brain-map.org/) (Lein et al., 2007).
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FIGURE 5 | Expression patterns of eNHE during normal brain
development. (A) Heat map of raw expression levels (from low/blue to
high/red) of eNHE in various regions of the mouse brain determined
from in situ hybridization data obtained from Allen Brain Atlas
(http://mouse.brain-map.org/) (Lein et al., 2007). Genetically identical,
inbred mice were used to limit individual differences and in situ data
were normalized to a specially created reference atlas of mouse brain
anatomy to control for differences between brain sections (Lein et al.,
2007). Abbreviations: LSC, Lateral septal complex; SDR, Striatum dorsal
region; THL, Thalamus; STR, Striatum; SVR, Striatum ventral region;
CRB, Cerebellum; OLF, Olfactory bulb; RHP, Retrohippocampal region;
PAL, Pallidum; HPF, Hippocampal formation; SAM, Striatum-like
amygdalar nuclei; PON, Pons; MID, Midbrain; HTH, Hypothalamus; MED,
Medulla; CTX, Cortex; HIP, Hippocampal region. (B) Heat map of
average human NHE6 and NHE9 RNA-seq gene expression (from
low/blue to high/red) plotted across different brain regions and different
development stages which include: prenatal period (embryogenesis to
birth), infancy (birth to 1 year), childhood (2–10 years), adolescence
(11–20 years), and adulthood (21+ years). NHE6 shows highest
expression prenatally during embryonic life, which lessens postnatally
and again peaks during adulthood. In contrast, NHE9 expression is far
lower embryonically, increases postnatally and peaks in the adulthood.
Notably, a strong correlation was observed for NHE6 with NRXN1 a
well-known autism candidate gene (red asterisk). (C) Hierarchical
clustering and expression heat-map (from low/blue to high/red) of eNHE
with 21 genes (Xu et al., 2012) with strong evidence for association
with autism showing clustering of eNHE with many synapse associated
autism genes during normal brain development. Notably, a strong
correlation was observed for NHE6 with NRXN1 a well-known autism
candidate gene (red asterisk). RNA-seq gene expression dataset
included a total of 578 samples represented as log base 2 of RPKM
values across different developmental periods and different brain regions
(available from: http://www.brainspan.org) (Sunkin et al., 2013).
Abbreviations: BA, Brodmann area; CTX, cortex; pcw, post-conception
weeks; mos, postnatal months; yrs, age in years; RPKM, reads per
kilobase of exon model per million mapped sequence reads.
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CELLULAR MODEL OF ENDOSOMAL NHE FUNCTION AT THE
SYNAPSE
As in non-neuronal cells, NHE6 and NHE9 show overlapping
distribution to early and recycling endosomal compartments of
neurons and astrocytes (Deane et al., 2013; Guterman, 2013;
Kondapalli et al., 2013; Ouyang et al., 2013), suggesting a shared
function in modulating ion homeostasis in these organelles.
Deane et al. showed punctate distribution of NHE6 through-
out the soma and dendrites of neurons that colocalizes with
endosomal markers and the AMPA receptor subunit GluA1.
Furthermore they showed enhanced recruitment of NHE6 to
dendritic spines following NMDAR-dependent long-term poten-
tiation, suggesting a role for NHE6 in learning and memory
(Deane et al., 2013).
A viable knockout model of NHE6 is available from Jackson
Labs (B6.129P2-Slc9a6tm1Dgen/J)4 with evidence of increased
propensity for drug-induced seizures. The model was engi-
neered by inserting the LacZ-Neo cassette into exon 6 of NHE6
that causes gene inactivation by introducing a stop codon
and a polyadenylation termination signal. Strømme et al. first
characterized this mouse model and showed that deletion of
NHE6 results in dysfunction of endosomal lysosomal system
and abnormal accumulation of GM2 ganglioside and unesteri-
fied cholesterol within late endosomes and lysosomes of neurons
and progressive loss of neurons and cerebellar Purkinje cells.
Behavioral tests showed motor hyperactivity, motor coordination
deficits and evidences of cerebellar dysfunction in NHE6 knock-
out mice (Stromme et al., 2011). Ouyang et al. showed that NHE6
deletion results in hyperacidic endosomes in neurons and altered
BDNF/TrkB signaling in vitro and proposed a role for NHE6 in
neuronal arborization and circuit strength based on experiments
in cultured neurons (Ouyang et al., 2013). Behavioral studies of
mousemodels are still forthcoming andmay validate the link with
autism, ADHD, and other neurological disorders.
No single neurobiological model currently explains ASD
and related neurological disorders; however, those involving the
synapse dominate cellular explanations. Neurons are morpholog-
ically, electrically, and chemically polarized cells. Tight regulation
of development and connectivity of the synapse is central to nor-
mal brain function. Astrocytes play an important supporting role
and have been implicated as critical players in syndromic autism
and other neurodevelopmental disorders (Molofsky et al., 2012).
The tripartite synapse includes the pre- and post-synaptic neuron,
supported and regulated by the astrocyte. We present a model of
eNHE function at all three components of the synapse. Although
speculative, thismodel is constructed from currently known func-
tions and a range of interesting, possible functions hypothesized
based on published literature. These hypotheses are presented as
a framework for future experimental testing and to spur more
active research in this area.
THE PRESYNAPTIC NEURON
Events at the presynaptic membrane are critically dependent
on the regulated trafficking of neurotransmitter-loaded synaptic
4B6.129P2-Slc9a6tm1Dgen/J. The Jackson Laboratory. Available online at: http://
jaxmice.jax.org/strain/005843.html
vesicles. The synaptic vesicle cycle is divided into discrete steps
comprising fusion, retrieval and neurotransmitter loading, with
potential roles for eNHE at each of these different stages
(Figure 6A).
(i) Synaptic vesicle fusion: NHE6 has been reported in presy-
naptic terminal and in synaptic vesicles storing both GABA
and glutamate, although its specific role remains to be
investigated (Gronborg et al., 2010; Deane et al., 2013).
Presynaptic vesicles make contact with the plasma mem-
brane along the active zone where fusion of the vesicle
membranes and exocytosis of the vesicle contents releases
neurotransmitters (Sudhof, 2012) as depicted in Step 1
(Figure 6). The ability of synaptic vesicles to dock and fuse at
the active zone of the presynaptic terminal begins with a pro-
cess called priming, in response to Ca2+ influx detected by
synaptotagmins, and proceeds by pairing of SNARE proteins
on the fusing membranes (Murthy and De Camilli, 2003).
Within the vesicle lumen, the proton pumping V-ATPase
acts in concert with chloride channels, Na+/K+-ATPase and
eNHE to establish ionic conditions (Edwards, 2007; Goh
et al., 2011). Together, they regulate vesicle pH, cation con-
centration and membrane potential. Recent evidence impli-
cates a direct role for the membrane domain (Vo) of the
V-ATPase in synaptic membrane fusion, via a molecular
interaction with the v-SNARE synaptobrevin (VAMP2) (Di
Giovanni et al., 2010). Based on their findings, the authors
speculate that optimal proton content is required for disso-
ciation of the Vo domain from the V1 domain for interaction
with VAMP2 (Morel et al., 2003; Di Giovanni et al., 2010).
By extension, the eNHE could provide a leak pathway for
protons and regulate luminal proton content to influence
fusion of the synaptic vesicles with the membrane (Step 1,
Figure 6A).
(ii) Synaptic vesicle endocytosis and trafficking: The mem-
brane of the fused vesicles undergoes lateral diffusion to
a region outside the active zone where it is retrieved by
endocytosis (Gundelfinger et al., 2003), depicted by Step
2 (Figure 6A). The assembly of proteins in defined stoi-
chiometry and their interaction withmembrane lipids create
microdomains that are required for assembling functional
synaptic vesicles (Hannah et al., 1999). In polarized liver
cells, regulation of endosomal pH by NHE6 directs sorting
of membrane lipids to the apical surface for maintenance
of cell polarity (Ohgaki et al., 2010). Similarly in polarized
neuronal cells, eNHE may be critical in securing defined
clusters of proteins and lipids at the synaptic membrane.
There is evidence that eNHE themselves are routed to the
endosomes by retrieval from the plasma membrane. Thus,
in HeLa cells, a dominant negative mutant of dynamin
reduces endosomal levels of NHE6 (Roxrud et al., 2009).
Luminal pH is known to affect budding and coating of vesi-
cles. In astrocytes, alkalinization of the endosomal lumen
by NHE9 resulted in a significant increase of receptor-
mediated endocytosis, as monitored by internalization of
tagged transferrin (Kondapalli et al., 2013). One mecha-
nism linking luminal pH to vesicle budding, again involves
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FIGURE 6 | Schematic of eNHE function at the synapse. (A) Presynaptic
Neuron: eNHE regulate luminal proton content to affect fusion of synaptic
vesicleswith the presynapticmembrane (Step 1). A role for eNHE inmembrane
assembly and endocytic retrieval of fused vesicles after the fused membrane
undergoes lateral diffusion is depicted (Step 2). eNHEmay influence the ratio
between electrical and chemical gradients by dissipating pH in favor of ,
thus controlling neurotransmitter loading (Goh et al., 2011) (Step 3). eNHEmay
also influence retrograde signaling in response to postsynaptic factors (Step 2;
Figure 6B). (B) Postsynaptic Neuron: Amodel of eNHE function is presented
in the context of membrane remodeling at dendritic spines (Step 1). Potential
regulation of eNHE by Rab-GAP protein is extrapolated from the yeast ortholog,
NHX1 and includes a possible interaction with Las17 ortholog WASP and the
Gyp6 ortholog TBC1D5 (Ali et al., 2004; Kallay et al., 2011). Cytosolic domains of
the eNHE bind scaffold protein RACK1, and the NHE6-Rack1 interaction
controls receptor recycling in cultured cells (Ohgaki et al., 2008). RAB-mediated
fusion and actin reorganization via WASP are required for membrane
remodeling. Retrograde signaling occurs via factors secreted by the
postsynaptic neuron that bind to receptors on the presynaptic membrane. A
role of eNHE in retrograde signaling is shown (Step 2; see also Figure 6A). (C)
Astrocyte: eNHEmodulate luminal pH of endocytic and exocytic pathways in
astrocytes (Kondapalli et al., 2013) to regulate vesicular trafficking, localization
and turnover neurotransmitter transporters and neurotropic factor receptors
(Step 1). Astrocytes surround synapses at which neurotransmitters are spilled
over to stimulate astrocytic receptors leading to propagation of Ca2+ transients
in astrocytes. Glial transmitters can be released from astrocytes in a Ca2+
dependent manner and can stimulate extra-synaptic receptors on adjacent
neurons, leading to a dynamic modification of synaptic transmission. eNHE
may differentially modulate the release of these gliotransmitters from the
astrocyte (Step 2). Endosomal pH in astrocytes has been shown to affect
cleavage of enzymes essential for Notch signaling, critical for astrocyte
migration and differentiation (Valapala et al., 2013). A role for eNHE in these
processes essential for migration and differentiation is depicted (Step 3).
the V-ATPase: in kidney proximal tubules, endosomal Vo
subunits transduce luminal pH signals to the vesicle assem-
bling machinery by recruiting the small GTPase ARF6 and
its cognate GTP/GDP exchange factor ARNO (Hurtado-
Lorenzo et al., 2006). Similarly, the eNHE may also interact
with trafficking machinery via their C-terminal cytoplasmic
domains. Indeed, the yeast eNHE ortholog NHX1 interacts
with, and is inhibited by the RAB-GTPase activating pro-
tein GYP6 to regulate luminal pH and vesicle trafficking
(Ali et al., 2004). It is intriguing to note that phenotypes
of null mutation in the δ subunit of AP3 clathrin adaptor
protein involved in vesicle assembly and budding, overlap
with those for eNHE, and include hyperactivity and epilep-
tic EEG signatures in the hippocampus (Kantheti et al.,
1998; Gilfillan et al., 2008). Mice with deletions in one of
the AP3 subunits show defects specifically in the biogen-
esis of GABA containing synaptic vesicles (Kantheti et al.,
1998). Similar defects in the inhibitory synapse could partly
account for seizures comorbid in ASD patients, associ-
ated with mutations in NHE6 and NHE9 (Gilfillan et al.,
2008; Morrow et al., 2008). These observations under-
score the emerging role of the endosomal pathway at
the synapse and in the pathology of neurodevelopmental
disorders.
(iii) Neurotransmitter loading: Newly endocytosed vesicles are
transported back to the active zone after being filled with
neurotransmitter, or translocated to a recycling endosome
from which new vesicles bud and are filled with neurotrans-
mitter on their way to the active zone (Gundelfinger et al.,
2003; Sudhof, 2012) (Step 3; Figure 6A). Neurotransmitter
uptake occurs through specific antiporters that harness one
or both components of the transmembrane proton motive
force: namely, the electrical () and chemical (pH)
gradient (Goh et al., 2011). The uptake of monoamines
and GABA is coupled to the pH gradient whereas glu-
tamate uptake is coupled to a membrane potential. The
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unidirectional pumping of H+ by V-ATPase generates a
membrane potential in the absence of charge compensation
by other transporters and channels. However, the resulting
 is variably converted to a proton chemical gradient by
the outward movement of positive charges (K+) or inward
movement of negative ions (Cl−) via ion channels (Goh
et al., 2011). Proton leak by eNHE tilts the ratio between
electrical and chemical gradients by dissipating pH in
favor of , thus controlling neurotransmitter loading.
Consistent with this, Goh et al. recently showed that mono-
valent Na+(K+)/H+ exchange activity promotes glutamate
filling into synaptic vesicles by converting pH into 
(Goh et al., 2011). Thus, the eNHE could regulate the con-
tent of synaptic vesicles to influence events at the presynaptic
terminal.
THE POSTSYNAPTIC NEURON
Synaptic plasticity underlies cognition, learning, and memory.
In the immature brain, altered synaptic signaling causes changes
in neuronal connectivity, resulting in predisposition to neuro-
logical disorders. A model of eNHE function is presented in
the context of membrane remodeling and retrograde signal-
ing, two critical molecular steps at the postsynaptic membrane
(Figure 6B).
(i) Postsynaptic membrane remodeling at dendritic spines:
Signal processing at the synapse is mediated by an integration
of excitatory and inhibitory inputs at the dendrites or the
cell body of the postsynaptic neuron (Matsuzaki et al., 2004;
Blanpied et al., 2008; Blanpied and Ehlers, 2011). An elaborate
cluster of neurotransmitter-coupled receptors and ion chan-
nels, membrane trafficking proteins, cell adhesion molecules,
signaling enzymes, cytoskeletal, and scaffolding proteins pack
into the postsynaptic density (PSD) of “spines” that decorate
the dendrites. A rich source of membrane bound organelles,
including mitochondria, recycling endosomes, and smooth
endoplasmic reticulum, underlies and supports the PSD.
Spine morphology is modified based on neuronal activity
and requires: (i) reorganization of the actin cytoskeleton and
scaffold proteins to change shape and size, and (ii) move-
ment of neurotransmitter receptors and ion channels on or
off the postsynaptic membrane to change synaptic strength.
It is worth noting that several NHE isoforms interact with the
actin cytoskeleton and scaffold proteins through their cyto-
plasmic C-terminal domains (Paradiso et al., 2004; Cha and
Donowitz, 2008; Donowitz et al., 2013) that range in size from
∼150 (NHE6–9) to ∼300 (NHE1–5) amino acids (Step 1;
Figure 6B). Although specific information on binding part-
ners of eNHE is scarce, it is intriguing that genetic variants in
NHE9 linked to autism or ADHD have been mapped to this
domain (de Silva et al., 2003; Morrow et al., 2008; Markunas
et al., 2010; Zhang-James et al., 2011).
Endosomes in dendritic spines serve as readily accessible stores for
membrane receptors, channels and membrane. Adding breadth
to a promising area of research, an elegant study by Park et al.
provided a mechanistic link between structural and functional
plasticity (Park et al., 2004). Using pH sensitive cargo, they
showed that upon receiving LTP inducing stimuli, recycling endo-
somes physically translocate to the spines where exocytosis of
the cargo is promoted, resulting in the enlargement of dendritic
spines. Inhibition of endosomal transport abolished the changes
observed in spine morphology (Park et al., 2004). Consistent
with a role in signal processing at the synapse, NHE6 was found
at dendritic spines partially colocalizing with AMPAR subunit
GluA1and exhibited enhanced translocation to dendritic spine
heads during NMDR dependent long-term potentiation (Deane
et al., 2013).
Garbern et al. identified a 9 base pair deletion in NHE6 in a
patient family characterized by severe intellectual disability, ASD,
and epilepsy. Postmortem samples of two males from the fam-
ily revealed deposition of tau fibrils in neurons and glia. Tau
phosphoproteins bind to microtubules and have been shown to
promote their assembly and stability. Based on their observations
and previously published studies the authors suggest that tau
deposition maybe mediated by interaction with mutant NHE6.
They speculate that interactions of eNHE with cytoskeletal ele-
ments may be critical for vesicular trafficking (Garbern et al.,
2010).
(ii) Retrograde signaling: Release of neurotrophic signals
and growth factors in an activity dependent manner by
postsynaptic membranes drives synaptic maturation and
growth through presynaptic endosomal signaling. This two-
way transmission between pre- and post-synaptic mem-
branes is essential for several processes including synapse
formation, growth and global synaptic plasticity (da Silva
and Wang, 2011). Genetic studies in rare familial cases indi-
cate that abnormal synapse formation may be an underlying
pathological pathway in autistic spectrum disorder (Arking
et al., 2008; Lawson-Yuen et al., 2008; Pescosolido et al.,
2012). Retrograde signaling occurs via factors secreted by
the postsynaptic neuron that bind to receptors on the presy-
naptic membrane (Step 2; Figure 6B) (da Silva and Wang,
2011). The physical separation between soma and axon ter-
minal requires the signal to travel long distances. Several
lines of evidence now support a vesicular-based transport
model with a “signaling endosome” capable of carrying the
entire signaling complex into the soma where it recapit-
ulates events that occurred at the axon terminal (Cosker
et al., 2008) (Figure 6A). An interesting question concerns
the factor(s) that regulate trafficking of this signaling endo-
some. How does the signaling endosome escape the recycling
and lysosomal routes and enter the axonal transport path-
way? Delcroix et al. showed that signaling endosomes of the
Nerve growth factor (NGF) correspond to early endosomes
(Delcroix et al., 2003), which was supported by Cui et al.
who used quantum dots to track NGF retrograde signaling
(Cui et al., 2007). Other studies suggest that RAB7-positive
(late) endosomes and multivesicular bodies are associated
with retrograde transport (Zerial and McBride, 2001; Rink
et al., 2005; Deinhardt et al., 2006). Although we do not
yet have a complete understanding of the endocytic path-
way, one characteristic difference between these endosomes
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is their luminal pH (e.g., recycling ∼6.5, late endosomes
∼6.0) (Brett et al., 2006; Casey et al., 2010), known to be
critically important for function (Brett et al., 2006; Casey
et al., 2010). Knockdown or overexpression of eNHE sig-
nificantly alters the pH of endosomes (Kondapalli et al.,
2013; Ouyang et al., 2013). We, and others have shown that
the change in pH arising from eNHE activity in the endo-
some results in altered cell surface expression of transferrin
receptors and consequently transferrin uptake (Ohgaki et al.,
2008; Kondapalli et al., 2013). Transferrin (Tfn) binds to
cell surface receptors (TfR) at an extracellular pH of 7.4
with nanomolar binding affinity. Tfn-TfR complex clusters
into clathrin coated pits to be delivered to early endosomes
where the V-ATPase lowers the pH of endosomes to facili-
tate the release of iron from Tfn. Apo-Tfn remains bound
to its receptor and is recycled back to the cell surface.
Modulation of luminal pH by eNHE affects the release of iron
from Tfn and consequently, recycling of internalized recep-
tor to the surface. Similarly, we hypothesize that the eNHE
may modulate dissociation of ligand-receptor dissociation
in the signaling endosome, altering synaptic growth and
neuronal connectivity to influence susceptibility to neuronal
disorders.
THE ASTROCYTE
The astrocyte, a type of glial cell, is an essential compo-
nent of the tripartite synapse, modulating synaptic function
for crucial determination of higher brain function and behav-
ior (Smith, 1994; Araque et al., 1999). There is strong evi-
dence that glial dysfunctions underlie psychiatric and brain
disorders including autism, epilepsy, taupathies, and schizophre-
nia (Molofsky et al., 2012). Patients with NHE6 mutations
present with prominent glial pathology (Garbern et al., 2010).
We showed that both NHE6 and NHE9 are expressed in
murine astrocytes, at levels slightly higher than those found
in cortical neurons (Kondapalli et al., 2013). Importantly,
manipulation of eNHE expression by knockdown or overex-
pression significantly altered endosomal pH (Kondapalli et al.,
2013). Although most studies linking endosomal pH to astro-
cyte function have focused on the V-ATPase, we are only
recently beginning to recognize the potential contribution of
eNHE.
(i) Neurotransmitter and neurotrophic factor clearance: At
the synapse, glial-specific ion channels and transporters
clear K+ ions that accumulate during neuronal activity and
remove neurotransmitters to terminate synaptic transmis-
sion. The neurotransmitter glutamate cannot be synthesized
by neurons, which must therefore rely on the astrocyte to
take up glutamate from the synaptic cleft, convert it into
glutamine, which is then shuttled back into neurons as a
renewable source of neurotransmitter. In murine astrocytes,
elevated levels of NHE9 significantly alkalinized endosomal
pH to increase cell surface expression and uptake activ-
ity of the glutamate transporter GLAST (Kondapalli et al.,
2013). Conversely, it is proposed that autism-associated loss
of function mutations in eNHE may reduce expression and
activity of glutamate transporters at the synapse, consistent
with elevated glutamate levels observed in patient brains,
and resulting in the observed predisposition to seizures.
Although, magnetic resonance spectroscopy (MRS) signal
abnormality from a clinical study in a single patient could
be open to a variety of different interpretations other than
problems in glutamate within the synapse, there are emerg-
ing studies that support a role for Na+(K+)/H+ exchange
in glutamatergic transmission (Vink et al., 2009; Goh et al.,
2011; Kondapalli et al., 2013). It has been shown that astro-
cytes affect synaptic plasticity by regulating the extracellular
availability of brain-derived neurotrophic factor (BDNF).
Neurons synthesize BDNF and release it in the precur-
sor form (pro-BDNF), which can then be processed in the
extracellular space by plasmin. Pro-BDNF promotes long-
term depression whereas themature form induces long-term
potentiation. As both these forms have opposite effects on
synaptic transmission, it is crucial to regulate their avail-
ability in the extracellular space. Pro-BDNF binds to p75
receptors on the astrocyte surface and is rapidly endocy-
tosed. The mechanisms regulating the recycling and release
of neurotransmitters and neurotropic factors are poorly
understood. The eNHE could potentially regulate these
processes by controlling pH within the lumen of endocytic
and exocytic pathways in astrocytes to regulate vesicular traf-
ficking, localization and turnover of critical components of
synaptic function, including neurotransmitter transporters
and neurotropic factor receptors (Step 1; Figure 6C).
(ii) Gliotransmitter release: Ca2+ oscillations in astrocytes
induce release of gliotransmitters (e.g., glutamate, D-serine,
ATP, tumor necrosis factor) that in turn can elicit neu-
ronal synchronization, synaptic modulation and plasticity
(e.g., by controlling insertion of AMPA receptors or regulat-
ing NMDA receptor function) (Parpura and Zorec, 2010).
Because glutamate uptake into synaptic vesicles is mediated
by VGLUT transporters that couple to the vesicular pro-
ton gradient, alkalinizing endosomal pH using the V-ATPase
inhibitor bafilomycin diminished glutamate release from
astrocytes, without suppressing Ca2+ elevations (Montana
et al., 2004). Similarly, sequestration of D-serine into glial
vesicles was dependent on pH and  as evidenced by
sensitivity to both nigericin (a K+/H+ exchanger) and vali-
nomycin (a K+ ionophore) that dissipate pH andmembrane
potential gradients respectively (Martineau et al., 2013). On
the other hand, V-ATPase inhibitors potently stimulated
exocytic release of the glial cell-derived neurotrophic factor
GDNF from a variety of glial cell lines (Nishiguchi et al.,
2003). Thus, endosomal pH is likely to differentially mod-
ulate release of various gliotransmitters and growth factors
from the astrocyte (Step 2; Figure 6C).
(iii) Astrocyte differentiation and migration: Notch signaling,
critical for astrocyte migration and differentiation, requires
cleavage by the γ-secretase enzyme within acidic endo-
lysosomal compartments. Recently, impairment of endo-
lysosomal acidification was shown to underlie defective
Notch processing and signaling in optic nerve astrocytes
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in the Nuc1 mutant rat (Valapala et al., 2013). Although
the mechanism underlying the loss of acidification is not
known, the authors speculate a dysfunction of the V-ATPase.
However, alterations in eNHE activity may also underlie
defects in endo-lysosomal pH and impact astrocyte differ-
entiation and migration (Step 3; Figure 6C).
CONCLUSIONS AND PROSPECTIVES
In summary, endosomal pH and membrane potential are set by
a balance of inward pumping of protons by V-ATPase and out-
ward leak via eNHE. Although the role of the ubiquitous H+
pumping V-ATPase has long been appreciated from previous
studies, this review highlights how eNHE activity is critical in
setting luminal pH and ion content by providing a leak pathway
for protons. Future studies investigating vesicular trafficking and
transport on synapse function, neuronal plasticity or differenti-
ation should take into account eNHE function. Finally, safe and
effective therapies for the treatment of autism and related disor-
ders remain a pressing need. It should be possible to counter the
effect of altering eNHE function by using drugs that act as weak
acids or bases to lower or raise the pH of endo-lysosomal com-
partments, respectively. Since membrane transporters are highly
“druggable” targets with proven success in the clinic, a search for
selective inhibitors or potentiators of eNHE activity should be
an immediate priority. Inhibitors against better-known plasma
membrane NHE isoforms could also be screened for efficacy
against eNHE using in silico (Faraone and Zhang-James, 2013),
in vitro, and in vivo approaches.
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